Taking Guesswork Out of Breast Tumor Diagnosis

The level of Estrogen Receptors (ER) in breast tumors dictates the form of treatment. However, up to 20 percent of ER test results could have been wrong. Now, with the development of breakthrough technology, exclusively available through HistoRx, ER test results are reliable.

A Patient Care Difference That Counts

The development of Automated Quantitative Analysis (AQUA) technology in detecting cancer markers in tumor tissue promises a new era of diagnostic accuracy. It was a quest born of frustration and opportunity, as HistoRx scientific founder Dr. David Rimm explains.

Measurement Aids Understanding

Breakthrough researcher and molecular pathologist Dr. Dana Faratian explains how biomarker quantification using tools like AQUA technology will play an increasingly important role in our understanding of cancers.